Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Phenyl 3 methylbenzofuran. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109384753B discloses a catalyst-free rearrangement for 2-phenyl-3-methylbenzofurans, offering a greener, cost-effective route for pharmaceutical intermediates.